PELOSI, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 13.395
NA - Nord America 9.695
AS - Asia 9.133
SA - Sud America 853
AF - Africa 162
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 8
Totale 33.301
Nazione #
US - Stati Uniti d'America 9.397
DE - Germania 5.225
GB - Regno Unito 2.941
SG - Singapore 2.797
CN - Cina 2.681
IT - Italia 1.449
SE - Svezia 880
RU - Federazione Russa 845
HK - Hong Kong 733
VN - Vietnam 707
BR - Brasile 603
BD - Bangladesh 526
FR - Francia 459
IN - India 443
TR - Turchia 366
IE - Irlanda 347
UA - Ucraina 345
KR - Corea 312
FI - Finlandia 251
NL - Olanda 244
CA - Canada 199
EU - Europa 172
JP - Giappone 135
CO - Colombia 118
ID - Indonesia 114
PL - Polonia 85
DK - Danimarca 52
ES - Italia 51
AU - Australia 49
IQ - Iraq 46
AR - Argentina 44
MX - Messico 41
GR - Grecia 38
AT - Austria 34
ZA - Sudafrica 33
BE - Belgio 29
TH - Thailandia 27
PH - Filippine 25
PK - Pakistan 25
SA - Arabia Saudita 24
EC - Ecuador 23
RO - Romania 21
MA - Marocco 20
CH - Svizzera 19
VE - Venezuela 19
MY - Malesia 18
DZ - Algeria 17
UZ - Uzbekistan 16
NP - Nepal 15
PE - Perù 15
PT - Portogallo 15
AE - Emirati Arabi Uniti 14
CI - Costa d'Avorio 13
IL - Israele 12
EG - Egitto 11
ET - Etiopia 11
NO - Norvegia 11
TN - Tunisia 11
CR - Costa Rica 10
HN - Honduras 10
JO - Giordania 10
KE - Kenya 9
LB - Libano 9
CL - Cile 8
PY - Paraguay 8
UY - Uruguay 8
IR - Iran 7
KG - Kirghizistan 7
TW - Taiwan 7
AZ - Azerbaigian 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
KH - Cambogia 6
KZ - Kazakistan 6
OM - Oman 6
AM - Armenia 5
HU - Ungheria 5
SN - Senegal 5
SR - Suriname 5
AO - Angola 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
HR - Croazia 4
JM - Giamaica 4
LK - Sri Lanka 4
LT - Lituania 4
NI - Nicaragua 4
PA - Panama 4
PR - Porto Rico 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BB - Barbados 3
CG - Congo 3
GT - Guatemala 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
Totale 33.397
Città #
Frankfurt am Main 4.094
Southend 2.660
Singapore 1.632
Ashburn 759
Chandler 678
Hong Kong 671
San Jose 640
Seattle 580
Beijing 548
Milan 468
Princeton 412
Dublin 342
Dallas 335
Wilmington 330
Council Bluffs 323
Fairfield 310
Santa Clara 276
Jacksonville 270
Los Angeles 262
Munich 249
Nanjing 199
Bengaluru 196
Woodbridge 189
Ho Chi Minh City 180
Lauterbourg 177
Redmond 175
Hanover 171
Des Moines 159
Hanoi 149
Boardman 145
Buffalo 145
New York 144
Houston 142
Ann Arbor 135
Mountain View 135
Moscow 127
Guangzhou 123
Shanghai 121
Sakarya 114
Somerville 114
Hefei 109
Chicago 106
Dearborn 106
Bogotá 100
Serra 98
Tokyo 97
Andover 94
Cambridge 88
Columbus 83
Berlin 82
Jinan 77
The Dalles 76
Tianjin 76
Jakarta 71
Helsinki 70
Warsaw 69
Shenyang 68
Nanchang 67
Phoenix 65
Cangzhou 64
Shenzhen 64
Ottawa 62
São Paulo 61
Dong Ket 60
Toronto 53
Rome 52
Redwood City 47
Hangzhou 44
Istanbul 43
Kiez 42
Salt Lake City 42
San Diego 41
Fuzhou 38
Hebei 38
Athens 35
Changsha 34
Seoul 34
Turin 34
Da Nang 32
Jiaxing 32
Sunnyvale 32
Eitensheim 31
Naples 31
Nuremberg 29
Haiphong 28
London 28
Zhengzhou 28
Elk Grove Village 26
Bühl 25
Rio de Janeiro 24
Atlanta 23
Falls Church 22
Verona 22
Hamburg 21
Washington 21
Baghdad 19
Tampa 19
Amsterdam 18
Brussels 18
Kunming 18
Totale 21.916
Nome #
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms 519
Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations 386
Prognostic role of lymph node involvement in lung metastasectomy 361
Long-term outcomes of a pilot CT screening for lung cancer 352
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers 352
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors 331
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status 320
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer 304
5 '-Nucleotidase (CN-II) emerges as a new predictive biomarker of response in the gemcitabine-cisplatin treatment of non-small cell lung cancer 303
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung 289
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal 283
Annual or biennial CT screening versus observation in heavy smokers : 5-year results of the MILD trial 279
Challenging lung carcinoma with coexistent δnp63/p40 and thyroid transcription factor-1 labeling within the same individual tumor cells 273
Comorbidities in idiopathic pulmonary fibrosis : an underestimated issue 272
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare 259
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 259
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors 257
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer 257
A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer 255
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor 250
Alterations of the Notch pathway in lung cancer 248
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer 248
Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules 246
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma 245
Localised thoracic sarcomas : outcome improvement over time at a single institution 238
Diagnosis and management of typical and atypical lung carcinoids 236
Primary thoracic synovial sarcoma : factors affecting long-term survival 235
Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S) : a proof for artifact 232
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology 228
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileum 227
Eriotinib-induced breast cancer regression 226
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening 223
3q26 amplification and polysomy of chromosome 3 in squamous cell lesions of the lung : a fluorescence in situ hybridization study 220
Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type 218
Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors 218
Clinical implications of lung neuroendocrine neoplasm classification 218
Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer : A baseline and 2-year repeat study 217
Survival rate of patients who develop cancer in rectal stump after colectomy and IRA in FAP patients 217
Screening-detected lung cancers: is systematic nodal dissection always essential? 214
Genomic characterization of asymtpomatic CT-detected lung cancers 213
Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk 212
Challenging diagnosis of an unusual solitary pulmonary nodule 211
High-resolution CT in smoking-related interstitial lung diseases 211
Giant Secondary Overgrowth of Type-1 Pulmonary Cystic Airway Malformation Upon Development of Anaplastic Lymphoma Kinase–Rearranged Adenocarcinoma 210
Lung cancer screening with low-dose computed tomography : A non-invasive diagnostic protocol for baseline lung nodules 209
Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung 206
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program 205
Genomic characterization of asymtpomatic CT-detected lung cancers 205
Assessment of overdiagnosis in CT screening for lung cancer 204
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation 203
Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer 202
Recent advances in the molecular landscape of lung neuroendocrine tumors 201
Pulmonary hypertension and chronic lung disease : where are we headed? 200
Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib 199
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women 199
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression 199
Classification of pulmonary neuroendocrine tumors: New insights 197
Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series 196
Cetuximab for colorectal cancer 193
Surgical damage control treatment of a large retroperitoneal liposarcoma encasing a horseshoe kidney 191
Synchronous bilateral lung carcinoid tumors: a rare entity? 191
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer 190
Lung cryobiopsy for the diagnosis of interstitial lung diseases: A series contribution to a debated procedure 189
Structural lung damage after chemotherapy, fact or fiction? 188
A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme 187
Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer 187
Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I nonsmall cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung 186
Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules 185
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 185
Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer 184
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy? 184
Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis 184
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature 180
CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung : relevance to prognosis in a subset of adenocarcinoma patients 179
Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib 179
Alteration of the E-cadherin/β-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids 178
Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis : preliminary results 177
Randomized Dose-Ranging Trial of Tamoxifen at Low Doses in Hormone Replacement Therapy Users 176
miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas 176
Lung cancer risk prediction to select smokers for screening CT : a model based on the Italian COSMOS trial 175
Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours 174
Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors : immunohistochemical study and gene expression analysis 173
Results of annual screening of lung cancer with low dose computed tomography in 5,000 high-risk individuals 173
Poorly differentiated synovial sarcoma of the vagina : first reported case with immunohistochemical, molecular and ultrastructural data 172
Detecting lung cancer in plasma with the use of multiple genetic markers 170
Study of inorganic particles, fibers, and asbestos bodies by variable pressure scanning electron microscopy with annexed energy dispersive spectroscopy and micro-Raman spectroscopy in thin sections of lung and pleural plaque 170
ΔNp63 (p40) distribution inside lung cancer : a driver biomarker approach to tumor characterization 170
Invited Commentary 168
The classification of lung carcinoma: time to change the morphology-based approach? 168
Therapy-Oriented large scale gene expression analysis In lung carcinoids 168
CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung : a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas 165
Structural lung damage after chemotherapy. fact or fiction? 165
Treatment of pulmonary metastases from primary intraosseous odontogenic carcinoma 164
Benign hyperplastic mesothelial cells in lymph node 162
Expression of gemcitabine and cisplatin-related genes according to histology and stage in non-small-cell lung cancer (NSCLC) 162
CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients 162
Clinical response of carcinomas harboring the BRD4–NUT oncoprotein to the targeted bromodomain inhibitor OTX015/MK-8628 162
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study 161
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung 158
Langerhans' cell histiocytosis 156
Totale 21.764
Categoria #
all - tutte 83.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.937 87 60 46 84 160 115 225 141 151 253 138 477
2022/20232.424 339 192 188 271 297 514 41 172 207 27 114 62
2023/20243.921 49 110 64 39 237 150 581 533 267 539 647 705
2024/20255.345 609 650 467 584 258 160 176 473 233 261 361 1.113
2025/20269.232 793 486 936 574 819 615 1.135 540 1.121 730 790 693
2026/2027343 343 0 0 0 0 0 0 0 0 0 0 0
Totale 34.901